Company Profile for TriMed Research, Inc.

[TriMed Research via BizWire]

--(BUSINESS WIRE)--TriMed Research, Inc.'s mission is to research
and commercially develop therapeutic products, primarily related to
the patented discovery of the mammary gland protein designated as MAA.
This discovery has many potential applications including the
prevention of life-threatening diseases of infants, reduction of the
incidence of farm animal disease, reduction of the debilitating
side-effects of cancer treatments and even the prevention of
"travelers' diarrhea."
The opportunities presented by the discovery of the MAA protein
lie in its antibacterial and antiviral properties. Unlike traditional
anti-infectives, however, MAA actually prevents gastro-intestinal
infection and could result in a new class of anti-infective compounds
with therapeutic applications for humans and animals.
A joint venture between a joint venture of the University of
Nebraska Medical Center, UNeMed Corporation and Tridelta Development,
Ltd., TriMed Research is headquartered in Omaha, Nebraska and also has
an office in California. Additional information can be obtained at
www.trimedres.com.

Company: TriMed Research, Inc.

Headquarters Address: 986099 Nebraska Medical Center
Omaha, NE 68198

Main Telephone: 402-559-8857

Website: www.trimedres.com

Type of Organization: Private

Industry: Health: Biotechnology

Key Executives: CEO: David Winter
Chairman: F. Joseph Daugherty
President: Brian Hett

Investor Relations
Contact: David Winter
Phone: 408-847-2747
Email: winte...@earthlink.net

Public Relations
Contact: Danielle Cagan
Phone: 415-665-6678
Email: dani...@cagancommunications.com